期刊
CLINICAL KIDNEY JOURNAL
卷 14, 期 2, 页码 550-555出版社
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfz181
关键词
calcium carbonate; phosphate binders; pre-dialysis patients; urinary fractional excretion of phosphate; vascular calcification
Calcium carbonate reduced urinary phosphate excretion and prevented the rise in phosphorus and iPTH serum levels, but was associated with increased vascular calcification. Calcium-based phosphate binders may not be a safe option for patients with CKD.
Background. Disordered bone and mineral metabolism are a common complication of chronic kidney disease (CKD). Phosphate binders are often prescribed in advanced CKD, when hyperphosphataemia develops. Little is known about the role of these drugs in earlier stages, when serum phosphorus levels are kept in the normal range by increased urinary excretion. Methods. A retrospective, controlled observational study was conducted on a cohort of 78 pre-dialysis patients. Subjects had CKD Stage 3 or 4, normal serum phosphorus levels and increased urinary fractional excretion of phosphate. Thirty-eight patients receiving calcium carbonate for 24 months were compared with 40 patients under no phosphate binders, regarding mineral metabolism parameters and vascular calcification scores. Results. Calcium carbonate decreased mean urinary fractional excretion of phosphate and median 24-h urine phosphorus, whereas no significant change was seen in the control group. Mean serum phosphorus and median serum intact parathyroid hormone (iPTH) remained stable in treated patients but increased in the control group. Vascular calcification, assessed by Kauppila and AdragAo scores, worsened under calcium carbonate with no significant change in the control group. Conclusions. Calcium carbonate reduced urinary phosphate excretion and prevented the rise in phosphorus and iPTH serum levels in a cohort of normophosphataemic pre-dialysis patients. However, treatment was associated with increased vascular calcification, suggesting that calcium-based phosphate binders are not a safe option for CKD patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据